Improved bioavailability of pefloxacin using controlled release ocular inserts

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 1, Issue SUPPL. 1, 2009, Pages 71-78

  Harish, N M ^a   Mathew, Nirmal ^a   Charyulu, R Narayana ^a   Prabhu, Prabhakara ^a  

^a NITTE DEEMED TO BE UNIVERSITY   (India)

Author keywords

Eudragit; HPMC; Ocular inserts; Pefloxacin

Indexed keywords

EUDRAGIT; EUDRAGIT RS; HYDROXYPROPYLMETHYLCELLULOSE; PEFLOXACIN;

ADSORPTION; ARTICLE; CONTROLLED DRUG RELEASE; CORNEA; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; EYE IRRITATION; OCULAR INSERT; RABBIT;

EID: 77953374310     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Robinson J.C., Ophthalmic Drug Delivery Systems, Mitra A. K. (Ed.), Marcel Dekker, New York, 1993, 29-57.
2. Sintze M.B., Bernatchez S. F., Tabatabay C. and Gurny R, Biomaterials in ophthalmic drug delivery, Eur. J. Pharm. Biopharm., 1996, 42, 358-374.
3. Le Bourlais C. A., Treupel-Acar L., Rhodes C.T., Sado P. T., Leverge R., New ophthalmic drug delivery systems, Drug Dev. Ind. Pharm. 1995, 21, 19-59.
4. Shell J.W., Ophthalmic drug delivery systems. Surv Ophthalmol., 1984, 29, 117-128.
5. Lee V.H.L. and Robinson J.R. Review: topical ocular drug delivery: recent developments and future challenges. J. Ocul. Phamacol., 1986, 2, 67-108.
6. Sultana Y, Mohammad A, Asgar A. Ocular inserts for controlled delivery of pefloxacin mesylate: Preparation and evaluation. Acta Pharm. 2005; 55:305-314.
7. H. Sasaki, T. Nagano, K. Sakanaka, S. Kawakami, K. Nishida, J. Nakamura, N. Ichikawa, J. Iwashita, T. Nakamura and M. Nakashima, One-side-coated insert as a unique ophthalmic drug delivery system, J. Control. Rel. 2003; 92: 241-247.
8. Abilash AS, Jayaprash S, Nagarajan M, Dhachinamoorthi D. Design and evaluation of timolol maleate ocuserts. Indian J Pharm Sci 2005; 67 (3): 311-314.
9. Seth AK, Agarwal GP, Saini TR. Evaluation of free films. Indian Drugs 1985; 23: 45-47.
10. Rao V, Shyale S. Preparation and Evaluation of ocular inserts containing norfloxacin. Turk J. Med Sci 2004; 34: 239-246.
11. H.M. El Laithy and K.M.F. El-Shaboury, AAPS. PharmSciTech. (2002); 3 (4) article 35 (http://www.aapspharmscitech.org).
12. Reddy KR, Mutalik S, Reddy S. Once-Daily Sustained-Release Matrix Tablets of Nicorandil: Formulation and In Vitro Evaluation. AAPS PharmSciTech. 2003; 4 (4): article 61.